ciprofloxacin has been researched along with Salmonella Infections, Animal in 47 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Salmonella Infections, Animal: Infections in animals with bacteria of the genus SALMONELLA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " CD nanocapsules were successfully employed for efficient targeting and killing of the intracellular pathogen at a dosage significantly lower than that of the free antibiotic." | 1.39 | Chitosan-dextran sulphate nanocapsule drug delivery system as an effective therapeutic against intraphagosomal pathogen Salmonella. ( Ben Thomas, M; Chakravortty, D; Elango, M; Gnanadhas, DP; Raichur, AM, 2013) |
| " The results show the importance of MPC in determining the correct dosage of Cip for treatment of Salmonella spp." | 1.37 | Mutant prevention concentration (MPC) of ciprofloxacin against Salmonella enterica of epidemic and poultry origin. ( Ferrari, R; Magnani, M; Oliveira, TC; Souza, RB; Tognim, MC, 2011) |
| "Clinafloxacin is a novel fluoroquinolone with a broad spectrum of antibacterial activity against both gramnegative and grampositive bacteria." | 1.30 | Clinafloxacin (CL 960) is superior to standard therapeutics in the treatment of murine listeriosis and salmonellosis. ( Bornitz, F; Hof, H; Kretschmar, M; Nichterlein, T, 1997) |
| " Single oral dosing of 20 mg/kg of either ofloxacin or ciprofloxacin showed that ofloxacin achieves approximately a four-fold higher peak serum or liver concentration than ciprofloxacin, which may contribute to its better efficacy in this infection model." | 1.28 | In-vivo evaluation of ofloxacin in Salmonella typhimurium infection in mice. ( Fu, KP; Hilliard, J; Isaacson, D; McGuire, JL; Rosenthale, ME; Tobia, AJ, 1990) |
| "Ciprofloxacin was considerably more effective than ampicillin in prolongation of the mean survival time of these mice." | 1.27 | Oral ciprofloxacin treatment for Salmonella typhimurium infection of normal and immunocompromised mice. ( Brunner, H; Zeiler, HJ, 1988) |
| "Fleroxacin was more potent than norfloxacin." | 1.27 | Comparative activities of norfloxacin and fleroxacin in experimental infections due to Salmonella typhimurium and Escherichia coli. ( Fabrig, J; Hof, H, 1988) |
| "Norfloxacin was ineffective at 200 mg/kg per day against E." | 1.27 | In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones. ( Bower, RR; Chu, DT; Fernandes, PB; Jarvis, KP; Ramer, NR; Shipkowitz, N, 1986) |
| " The progress of infection in sensitive mice with no natural immunity was delayed by ciprofloxacin although at the dosage used the mice were not cured." | 1.27 | Effect of ciprofloxacin on intracellular organisms: in-vitro and in-vivo studies. ( Blowers, A; Crane, JP; Easmon, CS, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (10.64) | 18.7374 |
| 1990's | 12 (25.53) | 18.2507 |
| 2000's | 10 (21.28) | 29.6817 |
| 2010's | 19 (40.43) | 24.3611 |
| 2020's | 1 (2.13) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S | 1 |
| Cui, S | 2 |
| McDermott, PF | 1 |
| Zhao, S | 1 |
| White, DG | 1 |
| Paulsen, I | 1 |
| Meng, J | 1 |
| Pränting, M | 1 |
| Negrea, A | 1 |
| Rhen, M | 1 |
| Andersson, DI | 1 |
| Kanvatirth, P | 1 |
| Rossi, O | 1 |
| Restif, O | 1 |
| Blacklaws, BA | 1 |
| Tonks, P | 1 |
| Grant, AJ | 1 |
| Mastroeni, P | 1 |
| Karraouan, B | 1 |
| Ziyate, N | 1 |
| Ed-Dra, A | 1 |
| Amajoud, N | 1 |
| Boutaib, R | 1 |
| Akil, A | 1 |
| El Allaoui, A | 1 |
| El Ossmani, H | 1 |
| Zerouali, K | 1 |
| Elmdaghri, N | 1 |
| Bouchrif, B | 1 |
| Braetz, S | 1 |
| Schwerk, P | 1 |
| Thompson, A | 1 |
| Tedin, K | 1 |
| Fulde, M | 1 |
| Leon, IM | 1 |
| Lawhon, SD | 1 |
| Norman, KN | 1 |
| Threadgill, DS | 1 |
| Ohta, N | 1 |
| Vinasco, J | 1 |
| Scott, HM | 1 |
| Love, WJ | 1 |
| Zawack, KA | 1 |
| Booth, JG | 1 |
| Gröhn, YT | 1 |
| Lanzas, C | 1 |
| Guo, X | 1 |
| Wang, H | 1 |
| Cheng, Y | 1 |
| Zhang, W | 1 |
| Luo, Q | 1 |
| Wen, G | 1 |
| Wang, G | 1 |
| Shao, H | 1 |
| Zhang, T | 1 |
| Haley, BJ | 1 |
| Kim, SW | 1 |
| Haendiges, J | 1 |
| Keller, E | 1 |
| Torpey, D | 1 |
| Kim, A | 1 |
| Crocker, K | 1 |
| Myers, RA | 1 |
| Van Kessel, JAS | 1 |
| Mahindroo, J | 1 |
| Thanh, DP | 1 |
| Nguyen, TNT | 1 |
| Mohan, B | 1 |
| Thakur, S | 1 |
| Baker, S | 1 |
| Taneja, N | 1 |
| Kim, JH | 1 |
| Cho, JK | 1 |
| Kim, KS | 1 |
| Gnanadhas, DP | 1 |
| Ben Thomas, M | 1 |
| Elango, M | 1 |
| Raichur, AM | 1 |
| Chakravortty, D | 1 |
| Teske, L | 1 |
| Ryll, M | 1 |
| Rubbenstroth, D | 1 |
| Hänel, I | 1 |
| Hartmann, M | 1 |
| Kreienbrock, L | 1 |
| Rautenschlein, S | 1 |
| Wasyl, D | 2 |
| Hoszowski, A | 2 |
| Zając, M | 2 |
| Raufu, IA | 1 |
| Fashae, K | 1 |
| Ameh, JA | 1 |
| Ambali, A | 1 |
| Ogunsola, FT | 1 |
| Coker, AO | 1 |
| Hendriksen, RS | 1 |
| Kern-Zdanowicz, I | 1 |
| Domańska-Blicharz, K | 1 |
| Bai, L | 1 |
| Zhao, J | 1 |
| Gan, X | 1 |
| Wang, J | 2 |
| Zhang, X | 1 |
| Xia, S | 1 |
| Hu, Y | 1 |
| Yan, S | 1 |
| Li, F | 1 |
| Fanning, S | 1 |
| Xu, J | 1 |
| Jurado-Tarifa, E | 1 |
| Torralbo, A | 1 |
| Borge, C | 1 |
| Cerdà-Cuéllar, M | 1 |
| Ayats, T | 1 |
| Carbonero, A | 1 |
| García-Bocanegra, I | 1 |
| Jiu, Y | 1 |
| Zhu, S | 1 |
| Khan, SB | 1 |
| Sun, M | 1 |
| Zou, G | 1 |
| Meng, X | 1 |
| Wu, B | 1 |
| Zhou, R | 1 |
| Li, S | 1 |
| Lin, CC | 1 |
| Chen, TH | 1 |
| Wang, YC | 1 |
| Chang, CC | 1 |
| Hsuan, SL | 1 |
| Chang, YC | 1 |
| Yeh, KS | 1 |
| Ferrari, R | 1 |
| Magnani, M | 1 |
| Souza, RB | 1 |
| Tognim, MC | 1 |
| Oliveira, TC | 1 |
| Tamang, MD | 1 |
| Nam, HM | 1 |
| Kim, TS | 1 |
| Jang, GC | 1 |
| Jung, SC | 1 |
| Lim, SK | 1 |
| Mueller-Doblies, D | 1 |
| Clouting, C | 2 |
| Davies, RH | 2 |
| Malorny, B | 1 |
| Schroeter, A | 1 |
| Guerra, B | 1 |
| Helmuth, R | 1 |
| Hsueh, PR | 1 |
| Teng, LJ | 1 |
| Tseng, SP | 1 |
| Chang, CF | 1 |
| Wan, JH | 1 |
| Yan, JJ | 1 |
| Lee, CM | 1 |
| Chuang, YC | 1 |
| Huang, WK | 1 |
| Yang, D | 1 |
| Shyr, JM | 1 |
| Yu, KW | 1 |
| Wang, LS | 1 |
| Lu, JJ | 1 |
| Ko, WC | 1 |
| Wu, JJ | 1 |
| Chang, FY | 1 |
| Yang, YC | 1 |
| Lau, YJ | 1 |
| Liu, YC | 1 |
| Liu, CY | 1 |
| Ho, SW | 1 |
| Luh, KT | 1 |
| Frana, TS | 1 |
| Carlson, SA | 1 |
| Rauser, DC | 1 |
| Jones, BD | 1 |
| Fergen, BJ | 1 |
| Griffith, RW | 1 |
| Tankson, JD | 1 |
| Fedorka-Cray, PJ | 1 |
| Jackson, CR | 1 |
| Headrick, M | 1 |
| Bertrand, S | 1 |
| Weill, FX | 1 |
| Cloeckaert, A | 1 |
| Vrints, M | 1 |
| Mairiaux, E | 1 |
| Praud, K | 1 |
| Dierick, K | 1 |
| Wildemauve, C | 1 |
| Godard, C | 1 |
| Butaye, P | 1 |
| Imberechts, H | 1 |
| Grimont, PA | 1 |
| Collard, JM | 1 |
| Threlfall, EJ | 4 |
| Day, M | 1 |
| de Pinna, E | 1 |
| Charlett, A | 1 |
| Goodyear, KL | 1 |
| Griggs, DJ | 1 |
| Hall, MC | 1 |
| Jin, YF | 1 |
| Piddock, LJ | 1 |
| Magallanes, M | 1 |
| Dijkstra, J | 1 |
| Fierer, J | 1 |
| Poppe, C | 1 |
| McFadden, KA | 1 |
| Brouwer, AM | 1 |
| Demczuk, W | 1 |
| Butler, T | 2 |
| Girard, AE | 1 |
| Contag, CH | 1 |
| Contag, PR | 1 |
| Mullins, JI | 1 |
| Spilman, SD | 1 |
| Stevenson, DK | 1 |
| Benaron, DA | 1 |
| Heisig, P | 1 |
| Kratz, B | 1 |
| Halle, E | 1 |
| Gräser, Y | 1 |
| Altwegg, M | 1 |
| Rabsch, W | 1 |
| Faber, JP | 1 |
| Reilly, WJ | 1 |
| Munro, DS | 1 |
| Nichterlein, T | 1 |
| Bornitz, F | 1 |
| Kretschmar, M | 1 |
| Hof, H | 2 |
| Angulo, FJ | 1 |
| Wall, PG | 1 |
| Page-Clisson, ME | 1 |
| Pinto-Alphandary, H | 1 |
| Chachaty, E | 1 |
| Couvreur, P | 1 |
| Andremont, A | 1 |
| Ridley, A | 1 |
| Liebana, E | 1 |
| Cassar, CA | 1 |
| Randall, LP | 1 |
| Walker, RA | 1 |
| Clifton-Hadley, FA | 1 |
| Ridley, AM | 1 |
| Fu, KP | 1 |
| Hilliard, J | 1 |
| Isaacson, D | 1 |
| Tobia, AJ | 1 |
| Rosenthale, ME | 1 |
| McGuire, JL | 1 |
| Brunner, H | 1 |
| Zeiler, HJ | 1 |
| Jacobs, MR | 1 |
| Farhi, D | 1 |
| Fabrig, J | 1 |
| Fernandes, PB | 1 |
| Chu, DT | 1 |
| Bower, RR | 1 |
| Jarvis, KP | 1 |
| Ramer, NR | 1 |
| Shipkowitz, N | 1 |
| Easmon, CS | 1 |
| Crane, JP | 1 |
| Blowers, A | 1 |
47 other studies available for ciprofloxacin and Salmonella Infections, Animal
| Article | Year |
|---|---|
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
Topics: Animals; Anti-Infective Agents; DNA Topoisomerases; Drug Resistance, Bacterial; Fluoroquinolones; Ge | 2007 |
Mechanism and fitness costs of PR-39 resistance in Salmonella enterica serovar Typhimurium LT2.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacterial Proteins; Cathelicidins; | 2008 |
Dual role of splenic mononuclear and polymorphonuclear cells in the outcome of ciprofloxacin treatment of Salmonella enterica infections.
Topics: Animals; Ciprofloxacin; Mice; Neutrophils; Salmonella enterica; Salmonella Infections; Salmonella In | 2020 |
Salmonella Kentucky: Antimicrobial resistance and molecular analysis of clinical, animal and environment isolates, Morocco.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Microbial Sensiti | 2017 |
The role of ATP pools in persister cell formation in (fluoro)quinolone-susceptible and -resistant strains of Salmonella enterica ser. Typhimurium.
Topics: Adenosine Triphosphate; Animals; Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; Drug Resistance, | 2017 |
Serotype Diversity and Antimicrobial Resistance among Salmonella enterica Isolates from Patients at an Equine Referral Hospital.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; DNA, Bacterial; Drug Resistance, | 2018 |
Phenotypical resistance correlation networks for 10 non-typhoidal Salmonella subpopulations in an active antimicrobial surveillance programme.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial | 2018 |
Quinolone resistance phenotype and genetic characterization of Salmonella enterica serovar Pullorum isolates in China, during 2011 to 2016.
Topics: Animals; Anti-Bacterial Agents; Chickens; China; Ciprofloxacin; Drug Resistance, Bacterial; Genotype | 2018 |
Salmonella enterica serovar Kentucky recovered from human clinical cases in Maryland, USA (2011-2015).
Topics: Animals; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; High-Throughput Nuc | 2019 |
Endemic fluoroquinolone-resistant Salmonellaenterica serovar Kentucky ST198 in northern India.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Humans; I | 2019 |
Prevalence and characterization of plasmid-mediated quinolone resistance genes in Salmonella isolated from poultry in Korea.
Topics: Animals; Blotting, Southern; Ciprofloxacin; DNA Primers; Drug Resistance, Bacterial; Electrophoresis | 2013 |
Chitosan-dextran sulphate nanocapsule drug delivery system as an effective therapeutic against intraphagosomal pathogen Salmonella.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Chitosan; Ciprofloxacin; Dextran Sulfate; Disease Models, | 2013 |
Epidemiological investigations on the possible risk of distribution of zoonotic bacteria through apparently healthy homing pigeons.
Topics: Adult; Animals; Anti-Bacterial Agents; Bird Diseases; Caco-2 Cells; Campylobacter Infections; Campyl | 2013 |
Prevalence and characterisation of quinolone resistance mechanisms in Salmonella spp.
Topics: Amino Acid Substitution; Animal Feed; Animals; Bacterial Proteins; Ciprofloxacin; DNA Gyrase; Drug R | 2014 |
Persistence of fluoroquinolone-resistant Salmonella enterica serovar Kentucky from poultry and poultry sources in Nigeria.
Topics: Animals; Anti-Bacterial Agents; Chickens; Ciprofloxacin; Cluster Analysis; Drug Resistance, Bacteria | 2014 |
High-level fluoroquinolone resistant Salmonella enterica serovar Kentucky ST198 epidemic clone with IncA/C conjugative plasmid carrying bla(CTX-M-25) gene.
Topics: Animals; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Ciprofloxacin; Drug Resistance, Mult | 2015 |
Emergence and Diversity of Salmonella enterica Serovar Indiana Isolates with Concurrent Resistance to Ciprofloxacin and Cefotaxime from Patients and Food-Producing Animals in China.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; China; Ciprofloxacin; DNA Topoisomerase | 2016 |
Genetic diversity and antimicrobial resistance of Campylobacter and Salmonella strains isolated from decoys and raptors.
Topics: Animals; Animals, Wild; Anti-Infective Agents; Bird Diseases; Campylobacter; Campylobacter Infection | 2016 |
Phenotypic and Genotypic Resistance of Salmonella Isolates from Healthy and Diseased Pigs in China During 2008-2015.
Topics: Animal Husbandry; Animals; Anti-Bacterial Agents; Cefotaxime; China; Ciprofloxacin; Drug Resistance, | 2017 |
Analysis of ciprofloxacin-resistant Salmonella strains from swine, chicken, and their carcasses in Taiwan and detection of parC resistance mutations by a mismatch amplification mutation assay PCR.
Topics: Animals; Anti-Infective Agents; Base Sequence; Chickens; Ciprofloxacin; Codon; Colony Count, Microbi | 2009 |
Mutant prevention concentration (MPC) of ciprofloxacin against Salmonella enterica of epidemic and poultry origin.
Topics: Amino Acid Substitution; Animals; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; DNA Gyra | 2011 |
Emergence of extended-spectrum beta-lactamase (CTX-M-15 and CTX-M-14)-producing nontyphoid Salmonella with reduced susceptibility to ciprofloxacin among food animals and humans in Korea.
Topics: Animals; Animals, Domestic; beta-Lactamases; Ciprofloxacin; Communicable Diseases, Emerging; DNA Tra | 2011 |
Investigations of the distribution and persistence of Salmonella and ciprofloxacin-resistant Escherichia coli in turkey hatcheries in the UK.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escheri | 2013 |
Incidence of quinolone resistance in strains of Salmonella isolated from poultry, cattle and pigs in Germany between 1998 and 2001.
Topics: Amino Acid Sequence; Animals; Anti-Infective Agents; Cattle; Ciprofloxacin; Colony Count, Microbial; | 2003 |
Ciprofloxacin-resistant Salmonella enterica Typhimurium and Choleraesuis from pigs to humans, Taiwan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Anti-Infective Agents; Child; Child, Preschool; | 2004 |
Effects of microcin 24-producing Escherichia coli on shedding and multiple-antimicrobial resistance of Salmonella enterica serotype typhimurium in pigs.
Topics: Animals; Anti-Bacterial Agents; Bacteriocins; Ciprofloxacin; Cloning, Molecular; Colony Count, Micro | 2004 |
Genetic relatedness of a rarely isolated Salmonella: Salmonella enterica serotype Niakhar from NARMS animal isolates.
Topics: Animals; Anti-Bacterial Agents; Blotting, Southern; Cattle; Cattle Diseases; Ciprofloxacin; Conjugat | 2006 |
Clonal emergence of extended-spectrum beta-lactamase (CTX-M-2)-producing Salmonella enterica serovar Virchow isolates with reduced susceptibilities to ciprofloxacin among poultry and humans in Belgium and France (2000 to 2003).
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Belgium; beta-Lacta | 2006 |
Assessment of factors contributing to changes in the incidence of antimicrobial drug resistance in Salmonella enterica serotypes Enteritidis and Typhimurium from humans in England and Wales in 2000, 2002 and 2004.
Topics: Ampicillin; Animals; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial | 2006 |
Quinolone resistance in veterinary isolates of Salmonella.
Topics: Animals; Anti-Infective Agents; Chickens; Ciprofloxacin; Conjugation, Genetic; DNA, Bacterial; Drug | 1994 |
Liposome-incorporated ciprofloxacin in treatment of murine salmonellosis.
Topics: Animals; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Carriers; Female; Injections, Int | 1993 |
Characterization of Salmonella enteritidis strains.
Topics: Animals; Bacterial Outer Membrane Proteins; Bacterial Typing Techniques; Bacteriophage Typing; Chick | 1993 |
Comparative efficacies of azithromycin and ciprofloxacin against experimental Salmonella typhimurium infection in mice.
Topics: Animals; Azithromycin; Ciprofloxacin; Colony Count, Microbial; Erythromycin; Female; Mice; Microbial | 1993 |
Photonic detection of bacterial pathogens in living hosts.
Topics: Animals; Anti-Infective Agents; Cells, Cultured; Ciprofloxacin; Disease Progression; Intestine, Larg | 1995 |
Identification of DNA gyrase A mutations in ciprofloxacin-resistant isolates of Salmonella typhimurium from men and cattle in Germany.
Topics: Adolescent; Animals; Anti-Infective Agents; Cattle; Cattle Diseases; Ciprofloxacin; Culture Media; D | 1995 |
Antibiotic resistance.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cattle; Ciprofloxacin; Drug Resistance, Multi | 1997 |
Clinafloxacin (CL 960) is superior to standard therapeutics in the treatment of murine listeriosis and salmonellosis.
Topics: Ampicillin; Animals; Anti-Infective Agents; Cells, Cultured; Ciprofloxacin; Female; Fluoroquinolones | 1997 |
Ciprofloxacin-resistant Salmonella typhimurium DT104.
Topics: Animal Diseases; Animals; Anti-Infective Agents; Cattle; Ciprofloxacin; Drug Resistance; Food Contam | 1998 |
Drug targeting by polyalkylcyanoacrylate nanoparticles is not efficient against persistent Salmonella.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Colistin; Cyanoacrylates; Drug | 1998 |
Molecular epidemiology of antibiotic resistance genes in multiresistant epidemic Salmonella typhimurium DT 104.
Topics: Animals; Anti-Infective Agents; Bacteriophage Typing; Ciprofloxacin; Disease Outbreaks; DNA Gyrase; | 1998 |
Comparison of gyrA mutations, cyclohexane resistance, and the presence of class I integrons in Salmonella enterica from farm animals in England and Wales.
Topics: Animals; Animals, Domestic; Anti-Infective Agents; Ciprofloxacin; Cyclohexanes; DNA Gyrase; Drug Res | 2002 |
In-vivo evaluation of ofloxacin in Salmonella typhimurium infection in mice.
Topics: Ampicillin; Animals; Chloramphenicol; Ciprofloxacin; Female; Liver; Mice; Microbial Sensitivity Test | 1990 |
Oral ciprofloxacin treatment for Salmonella typhimurium infection of normal and immunocompromised mice.
Topics: Administration, Oral; Ampicillin; Animals; Chloramphenicol; Ciprofloxacin; Female; Immune Tolerance; | 1988 |
Treatment of experimental Salmonella typhimurium infection in mice with fleroxacin.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Female; Fleroxacin; Mice; Salmonella Infections, Anim | 1988 |
Comparative activities of norfloxacin and fleroxacin in experimental infections due to Salmonella typhimurium and Escherichia coli.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Escherichia coli Infections; Female; Fleroxacin; Mice | 1988 |
In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Enterobacteriaceae In | 1986 |
Effect of ciprofloxacin on intracellular organisms: in-vitro and in-vivo studies.
Topics: Animals; Ciprofloxacin; Humans; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Mycobacter | 1986 |